miR-375 mediated acquired chemo-resistance in cervical cancer by facilitating EMT.
Acquired chemo-resistance is one of the key causal factors in cancer death. Emerging evidences suggest that miRNA and epithelial-mesenchymal transition play critical roles in the chemo-resistance in cancers. Here, we showed the association of paclitaxel-resistance with miR-375 over-expression and ep...
Guardado en:
Autores principales: | Yuanming Shen, Jiansong Zhou, Yang Li, Feng Ye, Xiaoyun Wan, Weiguo Lu, Xing Xie, Xiaodong Cheng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/54d10d36836e44f2b423201bfd009fc6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
miR-92a-3p Promoted EMT via Targeting LATS1 in Cervical Cancer Stem Cells
por: Shuangyue Liu, et al.
Publicado: (2021) -
Circulating miR-92b and miR-375 for monitoring the chemoresistance and prognosis of small cell lung cancer
por: Ming Li, et al.
Publicado: (2020) -
The promoter of the pri-miR-375 gene directs expression selectively to the endocrine pancreas.
por: Tali Avnit-Sagi, et al.
Publicado: (2009) -
Cell-specific detection of miR-375 downregulation for predicting the prognosis of esophageal squamous cell carcinoma by miRNA in situ hybridization.
por: Jiangchao Li, et al.
Publicado: (2013) -
A miR-375/YAP axis regulates neuroendocrine differentiation and tumorigenesis in lung carcinoid cells
por: Xiaojing Yang, et al.
Publicado: (2021)